Cite
MLA Citation
Shukui Qin et al.. “Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.” Lancet gastroenterology and hepatology, vol. 6, 2021, pp. 559–568. http://access.bl.uk/ark:/81055/vdc_100132727665.0x000003